A COVID-19 vaccine made in Taiwan by Medigen Vaccine Biologics Corp. has received emergency use authorization (EUA) in Paraguay after the unblinding of a Phase 3 clinical trial conducted in the South American country, the company said in a statement Monday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
Hualien quake causes brief transport delays, CWA warns of aftershocks
12/08/2025 09:50 PM - Society
- Business
Chiayi City to submit NT$6,000 cash handout plan for council review
12/08/2025 09:16 PM - Society
CWA forecasts heavy rain Tuesday, temperature drop to 10°C over weekend
12/08/2025 09:13 PM - Society
Taiwan forms clinical trial alliance to accelerate access to new medicines
12/08/2025 09:07 PM